OFFICIAL PUBLICATION OF

by its subsidiary APPco

GuildLink drives MedAdvisor revenue growth

Nicholas O’Donoghue 24/01/2023

Medication management platform, MedAdvisor’s acquisition of GuildLink is bearing fruit with the former Guild Group subsidiary making a significant contribution to the firm’s revenue growth. Announcing its 2023 financial year second quarter results (to 31 December 2022) to the Australian Securities Exchange (ASX), MedAdvisor CEO, Rick Ratliff, revealed global revenue was up 89.9 per

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Costs hinder recruitment of overseas pharmacists

Pharmacy needs the same thing as all allied health. Pay rises commensurate with experience and responsibilities. You can literally have…

Bob Tran

Costs hinder recruitment of overseas pharmacists

With due respect, not all pharmacists are trained up to the same standards. I have worked with many pharmacists from…

Blue Zorro

Costs hinder recruitment of overseas pharmacists

We sort of did in community pharmacy. Traineeship for a year, work as a pharmacist for 1-2 years, manage for…

Paul Sapardanis

Vyvanse still scarce

They are more than happy to lie to the public, as we saw with their statement on 60dd and possible…

D vL

GuildLink drives MedAdvisor revenue growth

Previous New HCF deal promises cheaper Ramsay pharmacy prices

Next Technology lagging on pharmacists’ needs

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous New HCF deal promises cheaper Ramsay pharmacy prices

Next Technology lagging on pharmacists’ needs

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.